Prescription drug · ANDA
Methimazole NDC 0832-6072
Methimazole 5 mg/1 · Tablet · Oral · Upsher-Smith Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0832-6072-11 | 00832607211 | 100 TABLET in 1 BOTTLE (0832-6072-11)Marketed from Mar 22, 2024 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methimazole
- Generic name (nonproprietary)
- methimazole
- Active ingredients
- Methimazole — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040547
- Marketing start
- Listing expires
- Other FDA classes
- Thyroid Hormone Synthesis Inhibitors (Mechanism)
- Identifiers
- Product ID 0832-6072_91b230bf-7e20-42fa-ba9c-6b986ce85ed2SPL ID 91b230bf-7e20-42fa-ba9c-6b986ce85ed2SPL set ID 2185e6e0-7c21-4348-a7b4-d898f50a0184RxCUI 197941, 197942UNII 554Z48XN5E
- Pharmacologic class
- Thyroid Hormone Synthesis Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400832607211followed by a unit qualifier and the quantityPackage 00832-6072-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Methimazole tablets are indicated: In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040547
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methimazole | Methimazole 5 mg/1 | TabletOral | AvKARE | 73190-084 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | AvKARE | 73190-085 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 0832-6073 |
| Methimazole | Methimazole 5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-011 |
| Methimazole | Methimazole 10 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | 11788-012 |